您当前的位置：
首页 >
文章列表页 >
Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells
更新时间：2024-04-03

    • Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 1, Pages: 95-102(2024)

    • DOI：10.13422/j.cnki.syfjx.20232025    

      CLC： R2-0;R22;R242;R285.5;R734.2

    • Received：26 May 2023，

      Published Online：23 August 2023，

      Published：05 January 2024

    移动端阅览

  • MU Qirui,LI He,LIU Yuetong,et al.Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(01):95-102. DOI： 10.13422/j.cnki.syfjx.20232025.

  •  
  •  

0

Views

46

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer via Nrf2/ROS Pathway
Buzhong Yiqitang Induces Ferroptosis by Regulating PCBP1 to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer
Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress via Nrf2/ROS/PERK/CHOP Signaling Pathway to Attenuate Cisplatin Resistance in NSCLC

Related Author

YU Dan
MU Qirui
LI He
LIU Yuetong
HUANG Jingyi
GAO Yuan
LIU Yuetong
LI He

Related Institution

College of Integrated Chinese and Western Medicine， Liaoning University of Traditional Chinese Medicine
College of Integrated Traditional Chinese and Western Medicine， Liaoning University of Traditional Chinese Medicine
Guangzhou University of Chinese Medicine
Lingnan Medical Research Center， Guangzhou University of Chinese Medicine
Liaoning University of Traditional Chinese Medicine（TCM）
0